Company Profile
Q-State Biosciences Inc.
Company Overview
Q-State Biosciences is a discovery technology and therapeutics company that applies a proprietary multi-discipline platform to discover genetically targeted therapeutics for neurodegeneration, epilepsy, pain and other disorders of the CNS. By integrating advanced human neuronal models, custom determinative measurement engineering and powerful AI/machine learning, we unlock unique insights into the biological complexity of the brain, its associated disease states and the creation of transformational medicines.
The Challenge
Traditional drug discovery efforts for CNS disorders have significant limitations. The CNS is a uniquely challenging field given the complexity of target tissue, and a translational gap exists where non-clinical models typically fail to reproduce human biology and deliver robust datasets. We have built our platform to traverse this gap.
Our Approach
We integrate powerful enabling technologies along three axes—advanced human biology, determinative measurement engineering, and algorithmic analysis—into a proprietary platform that redefines CNS drug discovery.
Our Vision
Our cutting-edge tools and capabilities form an integrated first-of-its-kind platform for addressing critical challenges in CNS therapeutic discovery. We are quickly progressing a pipeline of 12 internal proprietary and partnered collaboration programs, with 2 partnered programs expected to enter the clinic by the end of 2021.
Hear a description of our scientific vision from CSO Graham Dempsey on YouTube: https://youtu.be/R2h8mD03EmM
For more information, please visit www.qstatebio.com.